BioCardia (BCDA) Insider Trading & Ownership $2.18 0.00 (0.00%) As of 03:59 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends BioCardia (NASDAQ:BCDA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$64,354.50Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$6,514.00 Get BCDA Insider Trade Alerts Want to know when executives and insiders are buying or selling BioCardia stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BCDA Insider Buying and Selling by Quarter BioCardia Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/23/2024Peter AltmanCEOBuy1,000$2.06$2,060.00 12/20/2024Edward M GillisSVPSell3,257$2.00$6,514.00 12/5/2024Peter AltmanCEOBuy250$2.22$555.00 11/15/2024Peter AltmanCEOBuy1,350$1.87$2,524.50 7/1/2024Peter AltmanCEOBuy300$3.05$915.00 6/28/2024Peter AltmanCEOBuy200$2.99$598.00 6/21/2024Peter AltmanCEOBuy500$3.29$1,645.00 6/14/2024Peter AltmanCEOBuy500$3.52$1,760.00 6/10/2024Peter AltmanCEOBuy1,000$3.36$3,360.00 4/19/2024Peter AltmanCEOBuy183$5.55$1,015.65 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/28/2024Peter AltmanCEOBuy33$5.85$193.05 2/13/2024Peter AltmanCEOBuy7,207$6.90$49,728.30 (Data available from 1/1/2013 forward) BCDA Insider Trading Activity - Frequently Asked Questions Who is on BioCardia's Insider Roster? The list of insiders at BioCardia includes David Mcclung, Edward M Gillis, Peter Altman, and Phillip Md Et Al Frost. Learn more on insiders at BCDA. What percentage of BioCardia stock is owned by insiders? 20.00% of BioCardia stock is owned by insiders. Learn more on BCDA's insider holdings. Which BioCardia insiders have been buying company stock? The following insider purchased BCDA shares in the last 24 months: Peter Altman ($74,266.50). How much insider buying is happening at BioCardia? Insiders have purchased a total of 12,936 BCDA shares in the last 24 months for a total of $74,266.50 bought. Which BioCardia insiders have been selling company stock? The following insiders have sold BCDA shares in the last 24 months: Edward M Gillis ($6,514.00), and Phillip Md Et Al Frost ($55,811.85). How much insider selling is happening at BioCardia? Insiders have sold a total of 11,910 BioCardia shares in the last 24 months for a total of $62,325.85 sold. BioCardia Key ExecutivesDr. Peter A. Altman Ph.D. (Age 57)CEO, President & Director Compensation: $515.51kMr. David McClung (Age 61)Chief Financial Officer Compensation: $370.86kMr. Edward M. Gillis (Age 62)Senior Vice President of Devices Compensation: $263.1k1 recent trades More Insider Trading Tools from MarketBeat Related Companies LTRN Insider Trades TPST Insider Trades PASG Insider Trades ANEB Insider Trades CALC Insider Trades SNYR Insider Trades RLYB Insider Trades QTTB Insider Trades LUMO Insider Trades BIVI Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:BCDA) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
